Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-09

AUTHORS

Craig Beall, Elizabeth Haythorne, Xiaoning Fan, Qingyou Du, Sofija Jovanovic, Robert S. Sherwin, Michael L. J. Ashford, Rory J. McCrimmon

ABSTRACT

AIMS/HYPOTHESIS: Acute systemic delivery of the sulfonylurea receptor (SUR)-1-specific ATP-sensitive K(+) channel (K(ATP)) opener, NN414, has been reported to amplify glucose counter-regulatory responses (CRRs) in rats exposed to hypoglycaemia. Thus, we determined whether continuous NN414 could prevent hypoglycaemia-induced defective counter-regulation. METHODS: Chronically catheterised male Sprague-Dawley rats received a continuous infusion of NN414 into the third ventricle for 8 days after implantation of osmotic minipumps. Counter-regulation was examined by hyperinsulinaemic-hypoglycaemic clamp on day 8 after three episodes of insulin-induced hypoglycaemia (recurrent hypoglycaemia [RH]) on days 5, 6 and 7. In a subset of rats exposed to RH, NN414 infusion was terminated on day 7 to wash out NN414 before examination of counter-regulation on day 8. To determine whether continuous NN414 exposure altered K(ATP) function, we used the hypothalamic glucose-sensing GT1-7 cell line, which expresses the SUR-1-containing K(ATP) channel. RESULTS: Continuous exposure to NN414 in the setting of RH increased, rather than decreased, the glucose infusion rate (GIR), as exemplified by attenuated adrenaline (epinephrine) secretion. Termination of NN414 on day 7 with subsequent washout for 24 h partially diminished the GIR. The same duration of exposure of GT1-7 cells to NN414 substantially reduced K(ATP) conductance, which was also reversed on washout of the agonist. The suppression of K(ATP) current was not associated with reduced channel subunit mRNA or protein levels. CONCLUSIONS/INTERPRETATION: These data indicate that continuous K(ATP) activation results in suppressed CRRs to hypoglycaemia in vivo, which in vitro is associated with the reversible conversion of KATP into a stable inactive state. More... »

PAGES

2088-2092

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-013-2970-5

DOI

http://dx.doi.org/10.1007/s00125-013-2970-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043726951

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23793715


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypothalamus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "KATP Channels", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beall", 
        "givenName": "Craig", 
        "id": "sg:person.01000201464.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000201464.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haythorne", 
        "givenName": "Elizabeth", 
        "id": "sg:person.01053275125.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053275125.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale University", 
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Internal Medicine, Yale University, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fan", 
        "givenName": "Xiaoning", 
        "id": "sg:person.0717153373.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717153373.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Du", 
        "givenName": "Qingyou", 
        "id": "sg:person.01370271377.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370271377.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jovanovic", 
        "givenName": "Sofija", 
        "id": "sg:person.0577055337.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577055337.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale University", 
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Internal Medicine, Yale University, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sherwin", 
        "givenName": "Robert S.", 
        "id": "sg:person.0753661634.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753661634.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ashford", 
        "givenName": "Michael L. J.", 
        "id": "sg:person.014277206661.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014277206661.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McCrimmon", 
        "givenName": "Rory J.", 
        "id": "sg:person.01252203221.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252203221.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2337/diabetes.54.11.3169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001060379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.53.10.2542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004884721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-012-2617-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016862058", 
          "https://doi.org/10.1007/s00125-012-2617-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-012-2617-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016862058", 
          "https://doi.org/10.1007/s00125-012-2617-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db10-0103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019401227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1152/ajpregu.00531.2011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023379974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.53.3.549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036841570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbamcr.2010.01.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038976514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1152/ajpregu.00148.2006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043364243"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db06-1025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049003827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.1990.tb14116.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049647310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-8993(98)00956-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052836465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db08-0793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053511923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.37.5.495", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070741307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.48.3.584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070744109"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-09", 
    "datePublishedReg": "2013-09-01", 
    "description": "AIMS/HYPOTHESIS: Acute systemic delivery of the sulfonylurea receptor (SUR)-1-specific ATP-sensitive K(+) channel (K(ATP)) opener, NN414, has been reported to amplify glucose counter-regulatory responses (CRRs) in rats exposed to hypoglycaemia. Thus, we determined whether continuous NN414 could prevent hypoglycaemia-induced defective counter-regulation.\nMETHODS: Chronically catheterised male Sprague-Dawley rats received a continuous infusion of NN414 into the third ventricle for 8 days after implantation of osmotic minipumps. Counter-regulation was examined by hyperinsulinaemic-hypoglycaemic clamp on day 8 after three episodes of insulin-induced hypoglycaemia (recurrent hypoglycaemia [RH]) on days 5, 6 and 7. In a subset of rats exposed to RH, NN414 infusion was terminated on day 7 to wash out NN414 before examination of counter-regulation on day 8. To determine whether continuous NN414 exposure altered K(ATP) function, we used the hypothalamic glucose-sensing GT1-7 cell line, which expresses the SUR-1-containing K(ATP) channel.\nRESULTS: Continuous exposure to NN414 in the setting of RH increased, rather than decreased, the glucose infusion rate (GIR), as exemplified by attenuated adrenaline (epinephrine) secretion. Termination of NN414 on day 7 with subsequent washout for 24 h partially diminished the GIR. The same duration of exposure of GT1-7 cells to NN414 substantially reduced K(ATP) conductance, which was also reversed on washout of the agonist. The suppression of K(ATP) current was not associated with reduced channel subunit mRNA or protein levels.\nCONCLUSIONS/INTERPRETATION: These data indicate that continuous K(ATP) activation results in suppressed CRRs to hypoglycaemia in vivo, which in vitro is associated with the reversible conversion of KATP into a stable inactive state.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-013-2970-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5149808", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2634620", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2491974", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "56"
      }
    ], 
    "name": "Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro", 
    "pagination": "2088-2092", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d049d30c5a6f78c7469263b9ac45039f06ee77bfcfa503653f8e8230f74004e8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23793715"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-013-2970-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043726951"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-013-2970-5", 
      "https://app.dimensions.ai/details/publication/pub.1043726951"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89789_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-013-2970-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-2970-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-2970-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-2970-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-2970-5'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      21 PREDICATES      52 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-013-2970-5 schema:about N1a9fed1b734e4ace9e096e7aa4e02156
2 N2f1628c1c52c45319be37bc6407e716d
3 N46df93c86ecd449999d6f1631cfb3d98
4 N4c2844071f5345febc5214bc88391adc
5 N5e15ebafd5fd471e8990c9d62c62828d
6 Nd130f3ed85514a6a8acef9c965edba12
7 Nd85416372c434751be9d60599ac1fcfb
8 Ndaa7d15eb0ff4d1c8f0053a498ae56cb
9 Nfc36a6998f884edf8a14ddb74db42f6b
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N0fd6f8dd04fc46df98ee5546dfe55e58
13 schema:citation sg:pub.10.1007/s00125-012-2617-y
14 https://doi.org/10.1016/j.bbamcr.2010.01.018
15 https://doi.org/10.1016/s0006-8993(98)00956-1
16 https://doi.org/10.1111/j.1476-5381.1990.tb14116.x
17 https://doi.org/10.1152/ajpregu.00148.2006
18 https://doi.org/10.1152/ajpregu.00531.2011
19 https://doi.org/10.2337/db06-1025
20 https://doi.org/10.2337/db08-0793
21 https://doi.org/10.2337/db10-0103
22 https://doi.org/10.2337/diabetes.37.5.495
23 https://doi.org/10.2337/diabetes.48.3.584
24 https://doi.org/10.2337/diabetes.53.10.2542
25 https://doi.org/10.2337/diabetes.53.3.549
26 https://doi.org/10.2337/diabetes.54.11.3169
27 schema:datePublished 2013-09
28 schema:datePublishedReg 2013-09-01
29 schema:description AIMS/HYPOTHESIS: Acute systemic delivery of the sulfonylurea receptor (SUR)-1-specific ATP-sensitive K(+) channel (K(ATP)) opener, NN414, has been reported to amplify glucose counter-regulatory responses (CRRs) in rats exposed to hypoglycaemia. Thus, we determined whether continuous NN414 could prevent hypoglycaemia-induced defective counter-regulation. METHODS: Chronically catheterised male Sprague-Dawley rats received a continuous infusion of NN414 into the third ventricle for 8 days after implantation of osmotic minipumps. Counter-regulation was examined by hyperinsulinaemic-hypoglycaemic clamp on day 8 after three episodes of insulin-induced hypoglycaemia (recurrent hypoglycaemia [RH]) on days 5, 6 and 7. In a subset of rats exposed to RH, NN414 infusion was terminated on day 7 to wash out NN414 before examination of counter-regulation on day 8. To determine whether continuous NN414 exposure altered K(ATP) function, we used the hypothalamic glucose-sensing GT1-7 cell line, which expresses the SUR-1-containing K(ATP) channel. RESULTS: Continuous exposure to NN414 in the setting of RH increased, rather than decreased, the glucose infusion rate (GIR), as exemplified by attenuated adrenaline (epinephrine) secretion. Termination of NN414 on day 7 with subsequent washout for 24 h partially diminished the GIR. The same duration of exposure of GT1-7 cells to NN414 substantially reduced K(ATP) conductance, which was also reversed on washout of the agonist. The suppression of K(ATP) current was not associated with reduced channel subunit mRNA or protein levels. CONCLUSIONS/INTERPRETATION: These data indicate that continuous K(ATP) activation results in suppressed CRRs to hypoglycaemia in vivo, which in vitro is associated with the reversible conversion of KATP into a stable inactive state.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N68975b3f23f9423abfc0e40b2ffcb2b0
34 N9d80ddcf99314b1d90c2462f2e97e091
35 sg:journal.1001482
36 schema:name Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro
37 schema:pagination 2088-2092
38 schema:productId N2861e89e90fb4640b33c85af491fb0b5
39 N318c843ba66f491f900a3613d53cb0e3
40 N57f607189f2e48d7a1a250a05ae45b63
41 N704a65eefeeb4aadaf486da022d60edb
42 Ncbb8634e1e8143db8fd328c0e9de687e
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043726951
44 https://doi.org/10.1007/s00125-013-2970-5
45 schema:sdDatePublished 2019-04-11T09:51
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher N222e289e85bb453eaf57edc34ea0d307
48 schema:url https://link.springer.com/10.1007%2Fs00125-013-2970-5
49 sgo:license sg:explorer/license/
50 sgo:sdDataset articles
51 rdf:type schema:ScholarlyArticle
52 N020256ce95164897ac2e492ecdb3e0c4 rdf:first sg:person.01053275125.31
53 rdf:rest Nf772e8495b4947369e24c4e7300d87b6
54 N0fd6f8dd04fc46df98ee5546dfe55e58 rdf:first sg:person.01000201464.60
55 rdf:rest N020256ce95164897ac2e492ecdb3e0c4
56 N1a9fed1b734e4ace9e096e7aa4e02156 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Mice
58 rdf:type schema:DefinedTerm
59 N222e289e85bb453eaf57edc34ea0d307 schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 N2861e89e90fb4640b33c85af491fb0b5 schema:name readcube_id
62 schema:value d049d30c5a6f78c7469263b9ac45039f06ee77bfcfa503653f8e8230f74004e8
63 rdf:type schema:PropertyValue
64 N2f1628c1c52c45319be37bc6407e716d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Rats
66 rdf:type schema:DefinedTerm
67 N318c843ba66f491f900a3613d53cb0e3 schema:name doi
68 schema:value 10.1007/s00125-013-2970-5
69 rdf:type schema:PropertyValue
70 N3421ffa8a02d474d90261c13e0d8ce6c schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
71 rdf:type schema:Organization
72 N46df93c86ecd449999d6f1631cfb3d98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Glucose
74 rdf:type schema:DefinedTerm
75 N4c2844071f5345febc5214bc88391adc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Rats, Sprague-Dawley
77 rdf:type schema:DefinedTerm
78 N5435e90d8e8a448194e3356ce7a03dbe schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
79 rdf:type schema:Organization
80 N57f607189f2e48d7a1a250a05ae45b63 schema:name dimensions_id
81 schema:value pub.1043726951
82 rdf:type schema:PropertyValue
83 N5e15ebafd5fd471e8990c9d62c62828d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name KATP Channels
85 rdf:type schema:DefinedTerm
86 N68975b3f23f9423abfc0e40b2ffcb2b0 schema:issueNumber 9
87 rdf:type schema:PublicationIssue
88 N6ef9d6c40ba94e179c3d977e39c974ee rdf:first sg:person.01370271377.94
89 rdf:rest Nb2bbda329b8645b38ce4444a6ddba405
90 N704a65eefeeb4aadaf486da022d60edb schema:name nlm_unique_id
91 schema:value 0006777
92 rdf:type schema:PropertyValue
93 N92adfa7edf594c2f80cb01ded1c009a9 schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
94 rdf:type schema:Organization
95 N9d80ddcf99314b1d90c2462f2e97e091 schema:volumeNumber 56
96 rdf:type schema:PublicationVolume
97 Nb2bbda329b8645b38ce4444a6ddba405 rdf:first sg:person.0577055337.05
98 rdf:rest Neffc565761124edd91da011b7b4cb8c3
99 Nb34e5f731fcd445fb0f62ae6971875f5 schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
100 rdf:type schema:Organization
101 Ncbb8634e1e8143db8fd328c0e9de687e schema:name pubmed_id
102 schema:value 23793715
103 rdf:type schema:PropertyValue
104 Ncc481c6240f840189dea525295efd07f rdf:first sg:person.014277206661.23
105 rdf:rest Ne0e304e392c443df9052fa4a96f9d3fc
106 Nd130f3ed85514a6a8acef9c965edba12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Hypothalamus
108 rdf:type schema:DefinedTerm
109 Nd85416372c434751be9d60599ac1fcfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Male
111 rdf:type schema:DefinedTerm
112 Ndaa7d15eb0ff4d1c8f0053a498ae56cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Animals
114 rdf:type schema:DefinedTerm
115 Ndeb6793383c84fcd8ddbc6b257ae7d83 schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
116 rdf:type schema:Organization
117 Ne0e304e392c443df9052fa4a96f9d3fc rdf:first sg:person.01252203221.14
118 rdf:rest rdf:nil
119 Ne5da0917cd3f4a65beff96eb78be56f4 schema:name Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, Scotland, UK
120 rdf:type schema:Organization
121 Neffc565761124edd91da011b7b4cb8c3 rdf:first sg:person.0753661634.46
122 rdf:rest Ncc481c6240f840189dea525295efd07f
123 Nf772e8495b4947369e24c4e7300d87b6 rdf:first sg:person.0717153373.17
124 rdf:rest N6ef9d6c40ba94e179c3d977e39c974ee
125 Nfc36a6998f884edf8a14ddb74db42f6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cell Line
127 rdf:type schema:DefinedTerm
128 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
129 schema:name Medical and Health Sciences
130 rdf:type schema:DefinedTerm
131 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
132 schema:name Clinical Sciences
133 rdf:type schema:DefinedTerm
134 sg:grant.2491974 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-013-2970-5
135 rdf:type schema:MonetaryGrant
136 sg:grant.2634620 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-013-2970-5
137 rdf:type schema:MonetaryGrant
138 sg:grant.5149808 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-013-2970-5
139 rdf:type schema:MonetaryGrant
140 sg:journal.1001482 schema:issn 0012-186X
141 1432-0428
142 schema:name Diabetologia
143 rdf:type schema:Periodical
144 sg:person.01000201464.60 schema:affiliation N5435e90d8e8a448194e3356ce7a03dbe
145 schema:familyName Beall
146 schema:givenName Craig
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000201464.60
148 rdf:type schema:Person
149 sg:person.01053275125.31 schema:affiliation Ne5da0917cd3f4a65beff96eb78be56f4
150 schema:familyName Haythorne
151 schema:givenName Elizabeth
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053275125.31
153 rdf:type schema:Person
154 sg:person.01252203221.14 schema:affiliation N92adfa7edf594c2f80cb01ded1c009a9
155 schema:familyName McCrimmon
156 schema:givenName Rory J.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252203221.14
158 rdf:type schema:Person
159 sg:person.01370271377.94 schema:affiliation Nb34e5f731fcd445fb0f62ae6971875f5
160 schema:familyName Du
161 schema:givenName Qingyou
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370271377.94
163 rdf:type schema:Person
164 sg:person.014277206661.23 schema:affiliation N3421ffa8a02d474d90261c13e0d8ce6c
165 schema:familyName Ashford
166 schema:givenName Michael L. J.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014277206661.23
168 rdf:type schema:Person
169 sg:person.0577055337.05 schema:affiliation Ndeb6793383c84fcd8ddbc6b257ae7d83
170 schema:familyName Jovanovic
171 schema:givenName Sofija
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577055337.05
173 rdf:type schema:Person
174 sg:person.0717153373.17 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
175 schema:familyName Fan
176 schema:givenName Xiaoning
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717153373.17
178 rdf:type schema:Person
179 sg:person.0753661634.46 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
180 schema:familyName Sherwin
181 schema:givenName Robert S.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753661634.46
183 rdf:type schema:Person
184 sg:pub.10.1007/s00125-012-2617-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1016862058
185 https://doi.org/10.1007/s00125-012-2617-y
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.bbamcr.2010.01.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038976514
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s0006-8993(98)00956-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052836465
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1111/j.1476-5381.1990.tb14116.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049647310
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1152/ajpregu.00148.2006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043364243
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1152/ajpregu.00531.2011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023379974
196 rdf:type schema:CreativeWork
197 https://doi.org/10.2337/db06-1025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049003827
198 rdf:type schema:CreativeWork
199 https://doi.org/10.2337/db08-0793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053511923
200 rdf:type schema:CreativeWork
201 https://doi.org/10.2337/db10-0103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019401227
202 rdf:type schema:CreativeWork
203 https://doi.org/10.2337/diabetes.37.5.495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070741307
204 rdf:type schema:CreativeWork
205 https://doi.org/10.2337/diabetes.48.3.584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070744109
206 rdf:type schema:CreativeWork
207 https://doi.org/10.2337/diabetes.53.10.2542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004884721
208 rdf:type schema:CreativeWork
209 https://doi.org/10.2337/diabetes.53.3.549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036841570
210 rdf:type schema:CreativeWork
211 https://doi.org/10.2337/diabetes.54.11.3169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001060379
212 rdf:type schema:CreativeWork
213 https://www.grid.ac/institutes/grid.47100.32 schema:alternateName Yale University
214 schema:name Department of Internal Medicine, Yale University, New Haven, CT, USA
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...